Identifies biomarkers related to PANoptosis in HNSCC, suggesting new prognostic and therapeutic options.
This study identified four PANoptosis-related biomarkers in HNSCC, with ZBP1, RIPK1, and RNF31 as protective factors and FADD as a risk factor. These findings provide new references for improving the prognosis of HNSCC patients and developing novel therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Xia et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: